GLI3 and central nervous system cancer: Since the 1987 discovery of GLI1 in human glioma cells [12], the role of the three members GLI1, GLI2 and GLI3 in a variety of cancers has become increasingly apparent [4], with GLI1 expression specifically identified as a negative prognostic factor in numerous cancers [6,7].